Press release
Antibody Drug Conjugates Market Size, Share, Industry, Forecast and outlook (2024-2031)
DataM Intelligence
Global Antibody Drug Conjugates Market Achieves Remarkable Growth, Projected to Reach USD 16,594.6 Million by 2030
The global Antibody Drug Conjugates (ADCs) market has witnessed substantial growth, reaching a size of USD 5,032.8 million in 2022. According to market projections, the industry is set to experience a lucrative expansion, reaching up to USD 16,594.6 million by 2030, demonstrating a commendable Compound Annual Growth Rate (CAGR) of 16.6% during the forecast period from 2024 to 2031.
The driving force behind this robust growth is attributed to the escalating prevalence of cancer globally and the continual advancements in antibody engineering and conjugation technologies.
ADCs, at the forefront of targeted cancer treatment, effectively manage drug toxicity by directing potent compounds towards specific cells, thereby sparing healthy cells from harm.
Key Highlights:
YL201: A Pioneering ADC for Targeted Cancer Treatment
YL201, a notable ADC, comprises a monoclonal antibody targeting a tumor-associated antigen (TAA) linked to a cytotoxic agent with potential antineoplastic activity. Administered intravenously, YL201 selectively targets and binds to TAAs on tumor cells. Upon binding, the cytotoxic agent is released, executing an unknown mechanism of action to eliminate TAA-expressing cancer cells.
Market Dynamics
The global ADC market is propelled by factors such as the rising prevalence of cancer, escalating investments in cancer-related research and development, the surge in innovative and targeted cancer treatment options, and continuous advancements in antibody engineering and conjugation technologies.
Market Scope and Metrics
CAGR: 16.6%
Size Available for Years: 2021-2030
Forecast Period: 2024-2031
Data Availability: Value (USD)
Segments Covered: Application, Technology, and Region
Regions Covered: North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Fastest Growing Region: Asia-Pacific
Largest Region: North America
Insights Covered: Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other Key Insights.
To know more Insights - Download Sample: https://www.datamintelligence.com/download-sample/antibody-drug-conjugates-market
Market Segment Analysis
Application: The Breast Cancer segment dominates the market share, accounting for approximately 48.6% during the forecast period.
Geographical Share
North America: Holds the largest market share (51.4%) during the forecast period due to active new drug pipeline projects and new product launches. With 264 ADCs in pharma's pipeline, 161 are being developed in North America, making it the continent with the highest number of ADCs in development.
Major Companies
The major global players in the Antibody Drug Conjugates market include Takeda Pharmaceutical Company Ltd., Hoffmann-La Roche Ltd., Pfizer Inc., AstraZeneca, Gilead Sciences Inc., Seagen Inc., Astellas Pharma, Daiichi Sankyo Company Ltd., GlaxoSmithKline Plc, and ADC Therapeutics.
Related Reports:
basal insulin market: https://www.datamintelligence.com/research-report/basal-insulin-market
allergic rhinitis treatment market: https://www.datamintelligence.com/research-report/allergic-rhinitis-treatment-market
bleeding disorders treatment market: https://www.datamintelligence.com/research-report/bleeding-disorders-treatment-market
cerebral palsy treatment market: https://www.datamintelligence.com/research-report/cerebral-palsy-treatment-market
neurocutaneous syndrome market: https://www.datamintelligence.com/research-report/neurocutaneous-syndrome-market
inhalation anesthesia market: https://www.datamintelligence.com/research-report/inhalation-anesthesia-market
Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody Drug Conjugates Market Size, Share, Industry, Forecast and outlook (2024-2031) here
News-ID: 3396983 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Tobacco Testing Market Set for Strong Growth Amid Rising Health Re …
Market Overview:
The Tobacco Testing Market is estimated to reach at a CAGR of 4% during the forecast period 2024-2031.
The Tobacco Testing Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Tobacco Testing market report is an essential resource for market…
United States Refractory Metals Market Set for Strong Growth Driven by High-Temp …
Market Overview:
The Refractory Metals Market is growing at a CAGR of 1.8% during the forecast period 2024-2031.
The Refractory Metals Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Refractory Metals market report is an essential resource for market participants who…
United States Alternative Proteins Market Set for Explosive Growth: Driving Sust …
Market Size and Growth:
The Global Alternative Proteins Market Size was valued at US$ 25.7 Billion in 2022 and is expected to reach USD 81.9 Billion by 2031, exhibiting a CAGR of 15.6% during the forecast period (2025-2032)
The Alternative Proteins Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…
United States Meat Alternatives Market Surges as Consumers Embrace Plant-Based & …
Market Size and Growth:
The Global Meat Alternatives Market size value was USD 9.6 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 20.8 billion by 2031. The market is growing at a CAGR of 10.2% during the forecast period 2024-2031.
The Meat Alternatives Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth…
More Releases for ADC
ADC Market: Transforming Cancer Treatment
The global market for antibody-drug conjugates (ADCs) was valued at US$ 11.32 billion in 2023 and is expected to reach US$ 27.37 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.23% from 2024 to 2033. This growth is primarily driven by the increasing prevalence of cancer and the growing demand for safe and effective treatments.
Antibody Drug Conjugates: A Growing Force in Cancer Treatment and Market Expansion
Key…
With Knockout ADC Innovations, Creative Biolabs Took Center Stage at the 2024 Wo …
Creative Biolabs wrapped up a successful show at the 15th Annual World ADC San Diego in the beginning of November, where its third year of participation, highlighting its dedication to the advancement of antibody-drug conjugate (ADC) technology.
New York, USA - November 13, 2024 - Creative Biolabs seized the spotlight at Booth 313 by offering groundbreaking solutions across the entire ADC development spectrum, which demonstrate their unrivaled expertise and dedication to…
Showing Off Their ADC Game: Creative Biolabs Hits the 15th Annual World ADC Summ …
From November 4, Creative Biolabs will be back at the 15th Annual World ADC Summit in San Diego, marking its fourth year at the leading global gathering featuring innovative conjugates.
New York, USA - November 6, 2024 - Creative Biolabs invites all ADC enthusiasts, from new entrants to seasoned experts, to explore its comprehensive suite of ADC solutions and experience the latest in antibody-drug conjugate (ADC) innovation at Booth #313.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
"2023…
ADC Drugs For Breast Cancer Treatment
Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer treatment.
On February 24, 2023, The NMPA approved Enhertu, an injectable drug developed jointly by…
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Succe …
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Successive Approximation ADC, Delta-sigma ADC, and Others (Pipelined/Flash ADC)), and Application (Consumer Electronics and Industrial) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Full Report : https://www.alliedmarketresearch.com/analog-to-digital-converters-market
Increasing disposable income and technological advancements supplement the analog-to-digital converters market. However, complex design of the ADC hampers this market growth. On the other hand, encouragement in digitization of work processes by government in emerging economies,…
Global Data Converters Market Report 2017 (Analog to Digital Converter, Current …
The research report titled Global Data Converters Sales Market Report 2017 market size and forecast and overview on current market trends.
This report studies sales (consumption) of Global Data Converters Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
National Semiconductor
Nippon Precision Circuits Inc
Micro Analog systems
Microchip Technology.
TelCom Semiconductor, Inc
Vishay Siliconix
Texas…
